Tamil Nadu Urological Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-01-2025
- Paid Up Capital ₹ 5.88 M
as on 05-01-2025
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.38 Cr
as on 05-01-2025
- Revenue 18.43%
(FY 2022)
- Profit -131.38%
(FY 2022)
- Ebitda 940.50%
(FY 2022)
- Net Worth -4.03%
(FY 2022)
- Total Assets -5.76%
(FY 2022)
About Tamil Nadu Urological Research Centre
The Corporate was formerly known as Tamil Nadu Urological Research Centre Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.88 M.
The company currently has active open charges totaling ₹1.38 Cr.
Asirsam Nalindhasnayagam, Muthukathan Rajamanickam, Chinnaswami Rameshkumar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110TN1993PTC024202
- Company No.
024202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1993
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tamil Nadu Urological Research Centre?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeyaraman Ramanathan  | Director | 20-Dec-2018 | Current |
| Asirsam Nalindhasnayagam | Director | 12-May-2009 | Current |
| Muthukathan Rajamanickam | Director | 12-May-2009 | Current |
| Chinnaswami Rameshkumar | Director | 27-Oct-2014 | Current |
| Deepak Lamech | Director | 23-Aug-2021 | Current |
| Ramasamy Meyyappan | Director | 23-Aug-2021 | Current |
Financial Performance of Tamil Nadu Urological Research Centre.
Tamil Nadu Urological Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.43% increase. The company also saw a substantial fall in profitability, with a 131.38% decrease in profit. The company's net worth dipped by a decrease of 4.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tamil Nadu Urological Research Centre?
In 2020, Tamil Nadu Urological Research Centre had a promoter holding of 15.37% and a public holding of 84.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ge Capital Services India Creation Date: 21 Oct 2010 | ₹1.48 M | Open |
Ge Capital Services India Creation Date: 14 Dec 2007 | ₹4.00 M | Open |
Ge Capital Services India Creation Date: 30 Dec 2005 | ₹6.30 M | Open |
How Many Employees Work at Tamil Nadu Urological Research Centre?
Unlock and access historical data on people associated with Tamil Nadu Urological Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tamil Nadu Urological Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tamil Nadu Urological Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
